BridgeMD
New treatment option for Vitrification
Official title Validation of Donor Oocytes Semi-automated Vitrification
ClinicalTrials.gov ID: NCT06238570
What this study is testing
- What it's testing
- Oocyte vitrification is an effective method of freezing which has been authorized in France since 2011. The arrival of this technique has led to real improvements in the survival rate of oocytes after warming compared to that observed after slow freezing, a method previously applied.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 38, women only
You may be able to join if
- Egg donor
- Oocyte puncture for donation
- Good quality ovarian reserve (Antral follicle count evaluated by ultrasound: CFA ≥ 7)
- Negative serology status (HIV, hepatitis B and C, syphilis, CMV and HTLV)
- Absence of symptoms or COVID contact
You likely can't join if
- Decline to participate
- Pregnant and lactating woman
- Person under guardianship, curatorship, deprivation of liberty, protection of justice
See the full eligibility criteria
- Egg donor
- Oocyte puncture for donation
- Good quality ovarian reserve (Antral follicle count evaluated by ultrasound: CFA ≥ 7)
- Negative serology status (HIV, hepatitis B and C, syphilis, CMV and HTLV)
- Absence of symptoms or COVID contact
- Absence of genetic contraindication to egg donation
- Woman able to give informed consent to participate in research
- Woman affiliated to a social security scheme
- Decline to participate
- Pregnant and lactating woman
- Person under guardianship, curatorship, deprivation of liberty, protection of justice
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.